Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.
about
Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progressionCombining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cellsCCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinomaIdentification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer.Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-Methyl-l,3-Benzodioxole Isolated from the Fruiting Body of Antrodia camphorateStudy of the Anti-Proliferative Activity of 5-Substituted 4,7-Dimethoxy-1,3-Benzodioxole Derivatives of SY-1 from Antrodia camphorata on Human COLO 205 Colon Cancer CellsThe stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis.Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?Molecular targets and pathways involved in liver metastasis of colorectal cancer.Development of the LYVE-1 Gene with An Acidic-amino-acid-rich (AAAR) Domain in Evolution Is Associated with Acquisition of Lymph Nodes and Efficient Adaptive Immunity.Quantitative assessment of short amplicons in FFPE-derived long-chain RNA.Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.Screening of hub genes and pathways in colorectal cancer with microarray technology.The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats.Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research.Grb2 signaling in cell motility and cancer
P2860
Q21143876-FF392D38-8108-472A-A5FA-CC6BA7340FECQ21260390-B2A64CC0-1B49-43D8-9B02-96D7A255E495Q28741084-1839844E-8C30-495C-9B16-823643F972B2Q33511020-C0AC1418-819F-4437-9BCA-863033E22C5FQ33959517-118FD440-E307-46AF-85B3-DDE085C15503Q34192343-FC380988-9E0F-464F-ACBD-79FBE9C525A2Q35109732-0F584508-43BB-4A0B-9645-3007E0DBB4A4Q35111567-C5CBEF66-A381-45B1-9D8C-78A1DA1B6DE4Q35832205-1981BB7A-7B00-41B1-86E2-B141AE7B27E8Q37921797-53780067-0448-43C3-B322-46391461E3A8Q38535666-ED9F1E4C-910E-47B1-BF32-BB93B9357391Q40073882-44D1BC6C-2DD6-4C7A-A8F4-1677BFCABC7EQ42292545-6C55353A-15EE-4768-9E33-CE4457940BD3Q43242639-E55DB987-7F86-446E-8C14-4FA5B620F0B6Q46904587-33506C13-13A5-4081-9E3A-0A93BA6A6D01Q47445868-EBD0B68A-6259-43B8-A893-8340E45B9844Q51119567-183D0230-74AA-44E5-B8D4-66AE0CE20C2DQ58199697-091A9493-9334-472E-B889-77BDAE0653ED
P2860
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Targeting the EGFR, VEGFR, and ...... cells is required for therapy.
@en
type
label
Targeting the EGFR, VEGFR, and ...... cells is required for therapy.
@en
prefLabel
Targeting the EGFR, VEGFR, and ...... cells is required for therapy.
@en
P2093
P1476
Targeting the EGFR, VEGFR, and ...... cells is required for therapy
@en
P2093
Dominic Fan
Isaiah J Fidler
Jang-Seong Kim
Kim-Anh Do
Robert R Langley
Sun-Jin Kim
Takamitsu Sasaki
Toru Nakamura
Xuemei Wang
Yasuhiko Kitadai
P2860
P2888
P304
P356
10.1007/S10585-008-9153-7
P50
P577
2008-03-07T00:00:00Z
P6179
1033909745